Venmax Drugs and Pharmaceuticals share news, announcements and annual reports
BSE: 531015Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹14.00.
28 Oct: open ₹15.00, high ₹15.00, low ₹12.80
- Under BSE's graded surveillance, stage 0, on the list for 27 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15 Cr4,053rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Not shown: another business merged into the company on 30 Jun 2026, and the accounts this figure is made of do not include it yet. It returns once accounts of the company as it now is are filed. Price to book: how it is worked out
- Mergernew accounts awaited
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 15,688
Venmax Drugs and Pharmaceuticals share news and announcements
398 announcements, routine notices left out, newest first. Page 3 of 8.
Jan 2024
18 Jan · Non-Applicability Of Submission Of Corporate Governance Under Regulation 27(2) Of The SEBI (LODR) Regulations, 2015
16 Jan · Board meeting
Meeting on 16 Jan 2024
Nov 2023
14 Nov · Board meeting
6 Nov · Board meeting
Meeting on 14 Nov 2023: quarterly results
Oct 2023
21 Oct · Non-Applicability Of Submission Of Corporate Governance Under Regulation 27(2) Of The SEBI (LODR) Regulations, 2015
Sep 2023
6 Sep · Meeting
Aug 2023
11 Aug · Results
Jul 2023
31 Jul · Board meeting
Meeting on 11 Aug 2023: annual general meeting and quarterly results
May 2023
15 May · Board meeting
9 May · Board meeting
Meeting on 15 May 2023: audited results
Apr 2023
Feb 2023
18 Feb · Board meeting
Jan 2023
19 Jan · Board meeting
Meeting on 30 Jan 2023: quarterly results
Dec 2022
Nov 2022
Oct 2022
28 Oct · Board meeting
Meeting on 4 Nov 2022: quarterly results
Sep 2022
30 Sep · Meeting
30 Sep · Meeting
16 Sep · Reg. 34 (1) Annual Report.
16 Sep · Reg. 34 (1) Annual Report.
6 Sep · Board meeting
5 Sep · Board meeting
2 Sep · Board meeting
Meeting on 6 Sep 2022: annual general meeting2 Sep · Board meeting
Meeting on 5 Sep 2022: annual general meeting
Aug 2022
26 Aug · Certificate As Per Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended March 31, 2022